Fundz

Leo Cancer Care raised Series C financing to grow global footprint

PRIVATEJun 11, 2024

Round Type

Series C

EnglandBiotechnologyHealth CareMedicalMedical Device

Investors

Aviko RadiopharmaceuticalsMacmillan Cancer SupportWisconsin Alumni Research FoundationCone HealthMc Laren Healthcare Corporation

Description

Leo Cancer Care has secured Series C funding to advance the company's global ambitions for upright radiation therapy. The investment will aid in enhancing patient comfort and improving treatment accuracy, enabling the company to expand into Asian markets, particularly in Singapore, Japan, and South Korea.

Quick answer

Leo Cancer Care raised an undisclosed amount in a Series C round, dated June 11, 2024. Investors: Aviko Radiopharmaceuticals, Macmillan Cancer Support, Wisconsin Alumni Research Foundation, Cone Health and Mc Laren Healthcare Corporation. Leo Cancer Care is based in England, United Kingdom.

How much did Leo Cancer Care raise?
Leo Cancer Care raised an undisclosed amount in a Series C round on June 11, 2024.
Who invested in Leo Cancer Care?
Aviko Radiopharmaceuticals, Macmillan Cancer Support, Wisconsin Alumni Research Foundation, Cone Health and Mc Laren Healthcare Corporation are named as investors in this round.
What does Leo Cancer Care do?
Leo Cancer Care is a company dedicated to delivering radiation therapy in a more human way.
Where is Leo Cancer Care based and how big is it?
Leo Cancer Care is based in England, United Kingdom.
Who are the decision-makers at Leo Cancer Care?
Fundz holds 1 contact at Leo Cancer Care. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Leo Cancer Care that raised within 45 days of this round, from Fundz verified event records.

  • SoundHealth raised $7M (Seed) on July 24, 2024.
  • Clarapath raised $36M (Series B) on July 24, 2024.
  • JaxBio Technologies raised $2.7M (Grant) on July 24, 2024.
  • Kestra Medical Technologies raised $196M (Funding Round) on July 24, 2024.
  • Syntropic Medical raised $1.2M (Grant) on July 24, 2024.
  • Novocuff raised $26M (Series A) on July 17, 2024.

Who to call at Leo Cancer Care, and when

A new round usually means Leo Cancer Care is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Leo Cancer Care raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Leo Cancer Care, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Leo Cancer Care. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Leo Cancer Care

Location

England, United Kingdom

About

Leo Cancer Care is a company dedicated to delivering radiation therapy in a more human way. Their unique upright patient positioning and CT imaging system, named Marie®, offers a gantry-less approach and aims to reduce internal organ movement in patients receiving upright therapy. The company aims to expand its global footprint and is dedicated to providing more personalized care for cancer patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Leo Cancer Care raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Leo Cancer Care's next move

See what Strategic adds

Leo Cancer Care raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.